Vivoryon Therapeutics N.V. (AMS:VVY)
Netherlands · Delayed Price · Currency is EUR 1.642
+0.008 (0.49%)
Sep 5, 2025, 5:35 PM CET
Vivoryon Therapeutics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
43.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | -3.62M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 10.76M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionVivoryon Therapeutics News
- 1 day ago - Vivoryon Therapeutics NV (FRA:05Y) (H1 2025) Earnings Call Highlights: Strategic Advances Amid ... - GuruFocus
- 1 day ago - Half Year 2025 Vivoryon Therapeutics NV Earnings Call Transcript - GuruFocus
- 1 day ago - Vivoryon Therapeutics N.V. (VIVRF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Vivoryon Therapeutics N.V. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 9 months ago - Vivoryon Therapeutics NV (STU:05Y) Q3 2024 Earnings Call Highlights: Strategic Shifts and ... - GuruFocus
- 9 months ago - Q3 2024 Vivoryon Therapeutics NV Earnings Call Transcript - GuruFocus